BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Bio NC

  TheraSim Health IT Expert David Hadden to Share Innovative Technology to Improve Health Care at the Fifth Annual Health 2.0 Conference

  September 12, 2011

   · 

  3 min read
• Drug Development

  Sanofi (France) Release: Lyxumia(R) (lixisenatide) One-Step Regimen as Effective as Two-Step Regimen in Improving Glycemic Control in Type 2 Diabetes

  September 12, 2011

   · 

  6 min read
• Job Trends

  High Hopes for Gilead Sciences, Inc.'s “Quad” Studies as Company Eyes Foster City Expansion

  September 12, 2011

   · 

  1 min read
• Business

  Tensha Therapeutics Emerges With $15 Million Funding

  September 12, 2011

   · 

  4 min read
• Pharm Country

  Covance Inc. to Present at Morgan Stanley Global Healthcare Conference

  September 12, 2011

   · 

  2 min read
• Business

  Russia Takes Stake in Unusual British Drug Company; New Pharma Company Pro Bono Bio Launches Today

  September 12, 2011

   · 

  4 min read
• Drug Development

  RXi Pharmaceuticals Provides Positive NeuVax(TM) Phase 3 Clinical Trial Update; FDA Lifts Hold on Drug

  September 12, 2011

   · 

  4 min read
• Drug Development

  BioSante Pharmaceuticals, Inc. Successfully Completes LibiGel(R) Pharmacokinetic Study

  September 12, 2011

   · 

  5 min read
• Policy

  FDA Issues Complete Response Letter to Janssen Biotech Inc. for SIMPONI(R) Supplemental Biologics License Application

  September 12, 2011

   · 

  9 min read
• Product Recall Wipes $835 Million Off Cochlear Limited’s Value

  September 12, 2011

   · 

  1 min read